Atlas Trials

Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients

Clinical trial NCT03362073 · UNKNOWN

Trial details

NCT number
NCT03362073
Sponsor
Pusan National University Yangsan Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
KetamineRefractory Cancer Pain
Start date
2018-06-01
Primary completion
2021-12-31
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.